Aesthetic Health & Wellness
802 Scott Street · Covington, KY 41011
5.0(303 Google reviews · 29 in past year)
Retatrutide isn't available here yet. These are practices that treat weight and metabolic health, and some prescribe FDA-approved GLP-1s today. Inclusion does not mean a provider offers retatrutide.
802 Scott Street · Covington, KY 41011
5.0(303 Google reviews · 29 in past year)
509 Madison Avenue · Covington, KY 41011
4.9(119 Google reviews · 33 in past year)
1500 James Simpson Junior Way · Covington, KY 41011
4.4(97 Google reviews · 1 in past year)
1500 JAMES SIMPSON JR WAY · Covington, KY 41011
4.9(33 Google reviews · 18 in past year)
50 East Rivercenter Boulevard, 431 · Covington, KY 41011
Pins reflect street addresses where available; others are approximate (ZIP-level).
Be first to know when its status changes — join thousands already on the list.
No. Retatrutide is investigational and not FDA-approved, so it is not available by prescription in Covington or anywhere else in the U.S. The only legitimate routes today are clinical trials and Lilly's expanded access program, where your physician applies on your behalf and medical criteria must be met. RetaMaps tracks the status and the local providers most relevant to future treatment.
They are practices in medical weight management, obesity medicine, endocrinology, metabolic health, and related fields. Some currently advertise FDA-approved GLP-1 medications such as semaglutide or tirzepatide; each profile shows what the practice publicly advertises today.
Yes — 3 of the 5 tracked providers in this market indicate telehealth visits. State licensing rules determine whether a given telehealth practice can serve Kentucky residents; confirm with the practice.
No. Inclusion on RetaMaps does not mean a provider offers or will offer retatrutide — and no legitimate provider can prescribe it today. Where a practice has told RetaMaps directly that it expects to offer retatrutide if approved, we mark that clearly on its profile.
Join the RetaMaps update list with your email and ZIP. We'll email when retatrutide's regulatory or commercial status changes relevant to your area. It's informational — not a treatment queue.